Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped
First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...
Why Hims & Hers Stock Tumbled on Tuesday
Hims & Hers Health ( HIMS 7.49%) stock slid 7.4% through 11:10 a.m. ET Tuesday after Bank of America raised its price target ...
Why Hims & Hers Stock Popped on Monday
Hims & Hers Health (NYSE: HIMS) stock jumped 2.2% through 10:45 a.m. ET Monday after Morgan Stanley analyst Craig Hettenbach delivered some good news for the mail-order drugs stock. Citing third-party ...
Jumping Into The FDA Gamble: Initiating Hims & Hers With A Buy
Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...
Hims & Hers Has Superstar Potential, But It Will Take A Lot To Get There
Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...
Woman Says Her Husband of 6 Years Wants to Stay Married but End Their Romantic Relationship: 'I'm So Broken'
A woman says that her husband recently told her he no longer wants a romantic relationship with her, but would still like to ...
Woman Says Her Husband Is Calling Her ‘Unfair’ for Refusing to Try for a Second Baby at Age 41
A woman wrote on the U.K.-based forum Mumsnet that her husband wants to try for another baby now that their only kid is 18 ...
Hims & Hers’ Weight-Loss Empire Hits a Gut-Wrenching End
Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...